Rights and permissions
About this article
Cite this article
Donepezil a smart choice for mild-to-moderate AD in the UK. Pharmacoecon. Outcomes News 603, 3 (2010). https://doi.org/10.2165/00151234-201006030-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006030-00006